Try our Advanced Search for more refined results
Life Sciences - November, 2011
154 articles
- Boehringer Loses Bid To Decertify Sales Rep OT Action
- AAI Presses FTC To Block Express Scripts' Buy Of Rival
- Investors Sue Abbott Over $1.5B Depakote Settlement Tab
- Genentech Settles FCA Suit Over Cancer Drug For $20M
- Unsealed FCA Suit Accuses Pfizer Of Off-Label Marketing
- Pfizer Told To Cough Up Docs In Drug Marketing Action
- Pharmasset Investor Challenges $11B Gilead Deal
- Health Canada Bans Avastin For Breast Cancer Treatment
- Allergan Sues Apotex Again Over Generic Pinkeye Drug
- Dearth Of A 'Sales'man
- The Changing Scope Of Expert Witness Disclosures
- Lens Maker Sued Over Hazy Quality Control Standards
- The Downside To An Aggressive Defense
- FDA Chemist Settles Insider Trading Suit For $4M
- Producer Pleads Guilty To $2.6M Insider Trading Scheme
- Facebook Takes Responsibility For Merck Mix-Up
- AMO, Consumers Settle Contact Lens Marketing Action
- Pharmacies Turned Away By High Court In W.Va. Drug Suit
- ArthroCare To Pay $74M To End Stock Inflation Action
- Fordham Professor To Lead Fosamax Settlement Talks
- Supreme Court To Rule On GSK Reps' OT Status
- Giving Credit Where Credit Is Due
- Allergan Investors Sue Board Over Tax Tab For Exec Pay
- 8th Circ. Won't Rehear Heart Defect Drug Competition Suit
- Merck KGaA Accuses Merck & Co. Of Facebook Ambush
- Warner Targets Mylan's Plans For Generic Contraceptive
- Chattem Targeted Over Mouthwash Anti-Plaque Claims
- What Sets SciClone's FCPA Derivative Suit Apart
- Complying With Restrictions On Multisite Data Use
- Smith & Nephew Says Hologic Cut Into Its Surgical Patent
- Graceway Cleared To Sell Assets To Medicis For $455M
- EU Agency Calls For Recall Of US-Made Cancer Drugs
- Merck To Pay Nearly $1B To Settle Vioxx Marketing Claims
- FDA Chides Mylan Over Puerto Rico Plant Violations
- More Reasons To Discount Adverse Event Reports
- Darvocet, Darvon Suits Must Be Nixed After Mensing: Lilly
- Mylan Asks Fed Circ. To End Doryx ANDA Injunction
- Ropes & Gray Helps Pfizer Buy Anti-Scar Drug Co.
- Siemens Targeted Over Medical Scan Patent
- Is Inequitable Conduct Still A Viable Defense?
- Synthes Execs Sentenced Over Bone Cement Trials
- Novartis, Mylan Settle Feud Over Generic Vivelle-Dot
- Teva, Bayer Settle Dispute Over Levitra Patents
- 7th Circ. Affirms Lovenox Kickback Case Conviction
- Pfizer To Settle FCPA Bribery Probe For $60M
- Actelion To Appeal $415M Verdict Over CoTherix Buy
- Takeda Targets Rival Over Generic Diabetes Drug
- Duane Morris Woos 2 Deals Experts For Calif. Offices
- Looking For Loopholes In PLIVA V. Mensing
- Gilead Expands Hep C Efforts In $11B Skadden-Led Buy
- Valeant Buys INova From PE Firms For $688M
- Ex-Synthes Execs To Be Sentenced For 'Rogue' Trials
- Novartis Bone Drug Suit Falls Under NJ Damages Law: Court
- Bankrupt Graceway Faces Copyright Suit Over Drug Promos
- FrontPoint's Skowron Gets 5 Years For Insider Trading
- Class Action Attys Awarded $7M For 'Mona Lisa'-Like Work
- Fighting Reverse Payments In The Drug Industry
- FDA Bars Avastin's Use As Breast Cancer Treatment
- Kirkland Helps Bain Repurchase Physio-Control For $487M
- Watson Ducks Ky. Drug Price Inflation Suit
- Health Benefit Manager Expands Base In $250M Deal
- FDA Withholding Evidence In Birth Defects Suit: Attys
- Ex-Abbott Drug Rep Exempt From OT, Judge Says
- CooperVision Widens Contact Lens Recall
- Cigna Offers 15M Shares To Fund $4B HealthSpring Buy
- Sandoz, States Settle Drug Inflation Claims For $150M
- The Truth Is Out There, But Not Always On The Label
- FTC Nominees Weigh In On Pay-For-Delay Deals, Privacy
- Sens. Blast FDA's 'Slow' Device Approval Process
- Supplement Co. Accused Of Hiding Risky Ingredient
- APP Takes Angiomax Patent Extension Fight To Fed. Circ.
- Wyeth Resolves False Ad Fight Against Sun In 6th Circ.
- China Fines Cos. $1M Over Drug Ingredient Monopoly
- Olympus Investor Sues Over Merger Fee Scandal
- Blue Cross Sued Over 'Bait And Switch' Deductible Hikes
- Bard Ends Vessel Graft Patent Feud With Endologix
- Patent Group Rips America Invents In Tylenol Marking Suit
- Examining AIA's High-Speed Inter Partes Review System
- Merck Strikes Deal With Fla., NY, SC Over Vioxx Claims
- Anadys Shareholders Challenge $230M Sale To Roche
- Allergan Takes Aim At Lupin Over Lumigan ANDA
- Novartis Backs Medical Test Patent In High Court
- Failure-To-Warn Claims Need Fail-Proof Evidence In NJ
- ITC Refuses To OK Amgen, Roche Anemia Drug Deal
- FDA Unveils New Rules To Speed Up Medical Device Studies
- MSNBC Sued For Profits From Film About MJ's Doctor
- FDA Warns Int'l Isotopes Over Unapproved Thyroid Drug
- Fed. Circ. Nixes Teva Bid To Halt Generic Seasonique
- Ex-DHB Directors Strike $1.6M Deal To End SEC Fraud Suit
- J&J Wants Rivals' Marketing Data In Omnicare FCA Row
- Tightening The Noose Around TPP Claims
- Galderma Targets Amneal's Generic Rosacea Treatment
- Proskauer's New Beijing Office To Focus On M&A, PE
- HIPAA Enforcement Lacks Teeth Despite Changes: Panel
- Medco, Investors Settle Over $29B Express Scripts Merger
- DOJ Subpoenas Merck Over Avelox, Integrilin Marketing
- Top Female Deal Maker: Mayer Brown's Jodi Simala
- Abbott Can't Escape Suit Over Humira's Cancer Risks
- Frazier, Vivo Add To Rempex's $67.5M In Fundraising
- Merck Settles ERISA Suit Over Vioxx Claims For $50M
- Affymax To Pay J&J Unit $13M In Anemia Drug IP Dispute
- Back To The Future With Medicare Bundled Payments
- Ore. Says McKesson Artificially Inflated Drug Prices
- Toxic Torts: Designation For Causation
- Case Study: Turek V. General Mills
- GSK Prodded Toward Mediation In Avandia MDL
- Calif. Pharmacies Sue Pfizer, Ranbaxy Over Lipitor Deal
- Warner Chilcott Targets Cadila Over Generic Asacol
- Sens. Probe Cigna, Quest, Others Over Lab Kickbacks
- St. Jude Vascular Device Patent Protected By Law: Judge
- 9th Circ. Keeps Investor Class Intact In Anemia Drug Fight
- Amylin, Lilly Wrap Up Diabetes Drug Alliance, Lawsuit
- Goodwin Helps TA Snag Senior Whole Health For $135M
- Top Female Deal Maker: Dewey & LeBoeuf's Jane Ross
- Savient Investor Asks 2nd Circ. To Reopen Fraud Case
- Hines Drops $160M For Boston-Area Office Park
- AstraZeneca Indicted In Serbia Over Doctor Payments
- Federal Preemption For Generic OTC Drugs?
- GSK, Colgate Put Toothpaste Nurdle IP Battle Behind Them
- Judge Finds Valeant's Antidepressant Patents Valid
- Pfizer, Aurobindo Reach Accord In Lipitor Patent Case
- CVS, KV Resolve $100M Suit Over Drug Supply Contract
- Knee Device Maker Sues Plaintiffs Firm Over Ads
- Amgen Launches $5B Stock Buyback, Senior Notes Offering
- Allergan Faces Medicaid Fraud Probe By Mass. AG
- Jenner Reps General Dynamics' $360M Force Protection Buy
- AstraZeneca Asks Fed. Circ. To Bar Generic Crestor
- Simpson Aids JLL In $398M American Dental Purchase
- Lilly Wins First Zyprexa Liability Trial
- Top Legal Talent Take Center Stage In MF Global Suits
- Takeda Sued Again Over Diabetes Drug's Cancer Risks
- FDA Overrules Staff To Broaden Approval Of J&J's Xarelto
- Great Point Grabs Stake In Remote Radiology Startup
- Novartis Fights Actavis' Generic Dementia Patch
- EU Puts Spotlight On $21B J&J-Synthes Merger
- Acella Clears Up Medicis Acne Treatment Patent Suit
- Judge Nixes Last 2 Wrongful Death Suits In Digitek MDL
- 10th Circ. Upholds FDA Win In Morphine Exemption Suit
- Reed Smith Health Privacy Atty Jumps To King & Spalding
- Holding Rogue Employees Accountable Under The FCA
- GSK To Pay $3B To Settle US Avandia, Medicaid Probes
- Pharm Co. Breckenridge Sues Rivals Over Generic Laxative
- Cephalon Targets Breckenridge Over Nuvigil Patent
- Pharma Tech Co. Targets Rival Over Tracking Device IP
- Sandoz Settles Iowa, NY Drug Price Inflation Claims
- Adolor Investor Challenges Cubist's $415M Takeover Bid
- HSG Gene Sequence Patent Valid: UK High Court
- AXA Private Equity Carves Out Rhodia's Aspirin Unit
- Quinn Emanuel Adds Departing Novartis GC In Europe
- Express Scripts, Medco Deal Slammed By Small Biz Group
- Stiefel Will Get Split Trial For ERISA, Stock Fraud Claims
- Top Female Deal Maker: Shearman's Christa D'Alimonte
- Novartis Shakes Suit Over Bone Drug Warnings
- Olympus Committee To Probe Merger Fee Scandal